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Abstract
Cancer genomes exhibit a large number of different alterations that affect many genes in a diverse manner. It
is widely believed that these alterations follow combinatorial patterns that have a strong connection with the
underlying molecular interaction networks and functional pathways. A better understanding of the genera-
tive mechanisms behind the mutation rules and their influence on gene communities is of great importance
for the process of driver mutations discovery and for identification of network modules related to cancer
development and progression. We developed a new method for cancer mutation pattern analysis based on a
constrained form of correlation clustering. Correlation clustering is an agnostic learning method that can be
used for general community detection problems in which the number of communities or their structure is not
known beforehand. The resulting algorithm, named C3, leverages mutual exclusivity of mutations, patient
coverage, and driver network concentration principles; it accepts as its input a user determined combina-
tion of heterogeneous patient data, such as that available from TCGA (including mutation, copy number,
and gene expression information), and creates a large number of clusters containing mutually exclusive mu-
tated genes in a particular type of cancer. The cluster sizes may be required to obey some useful soft size
constraints, without impacting the computational complexity of the algorithm. To test C3, we performed a
detailed analysis on TCGA breast cancer and glioblastoma data and showed that our algorithm outperforms
the state-of-the-art CoMEt method in terms of discovering mutually exclusive gene modules and identifying
driver genes. Our C3 method represents a unique tool for efficient and reliable identification of mutation
patterns and driver pathways in large-scale cancer genomics studies.
1 Introduction
Rapid advances in high-throughput sequencing technologies have provided unique opportunities for analyzing
large numbers of cancer genomes. However, the complexity of genomic alterations in cancer remains a chal-
lenge that has to be overcome in order to fully characterize the functional roles of various mutations. Cancer
genomes often exhibit a large number of different mutations that affect genes in diverse manners. But the vast
majority of these mutations do not have significant impact on tumorigenesis [18]. A central question in cancer
genomics is how to distinguish “driver” mutations, which contribute to tumorigenesis, from functionally neutral
“passenger” mutations. Such driver mutations (e.g., point mutations or copy number changes) are of critical
importance in elucidating key biological pathways perturbed in cells that eventually lead to cancer.
Many computational methods have been developed to facilitate the discovery of driver mutations [6, 11, 16,
22, 26]. Due to the high level of inter-tumor heterogeneity, two patients with the same cancer may have vastly
different drivers and most cancer mutations occur in very low frequency in the patient population. Therefore,
approaches relying on simple recurrence or frequency of mutations do not work well in practice. Recently,
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pathway-based and network-based models have been shown to be effective not only in determining common
driver mutations and mutation patterns, but also in pinpointing the key biological pathways and subnetworks
affected by driver mutations [4, 20, 29–31]. Such methods have a unique advantage in so far that in addition to
mutation analysis, they take into account gene interactions as an added source of prior knowledge.
In parallel, a number of methods have been proposed to identify driver pathways, i.e., groups of genes
that may interact together in combinatorial patterns to promote tumorigenesis. The authors of (9) described a
method called MEMo, and subsequently used it to show that mutually exclusive modules based on known net-
works can aid in determining groups of genes that contribute to tumorigenesis. These gene groups, or modules,
are jointly highly recurrent, have similar pathway impact in terms of biological processes, and their corre-
sponding mutations tend to be mutually exclusive, meaning that very often only one gene in each gene group is
mutated at a given time in any given patient. This mutual exclusivity rule in cancer pathways is supported by
the observations that, in general, one mutated gene suffices to perturb the function of its corresponding pathway.
Multiple mutations would require significantly higher energy investments on the part of cancer cells, and are
hence selected against. Dendrix [41] (and later Multi-Dendrix [23]) was developed to identify driver pathways
de novo using mutual exclusivity and coverage (recurrence) principles, without relying on known network infor-
mation that has the potential to improve the discovery process of new modules. More recently, CoMEt [24] was
proposed to address an inherent bias in Dendrix and Multi-Dendrix that resulted in high frequency mutations
being significantly more likely to be included in mutually exclusive modules.
However, while Dendrix, Multi-Dendrix and CoMEt have the ability to identify mutually exclusive mod-
ules de novo, there still have significant limitations. These methods are typically very inefficient when it comes
to applying them on large-scale datasets with large parameter setting. Also, some of these methods are ran-
domized in nature and no guarantees exist that multiple runs of the methods will produce compatible results.
Furthermore, almost all methods are able to identify only a small number of modules with limited number of
genes, as cluster sizes are critical algorithmic parameters from the perspective of computational tractability.
To overcome these and other shortcomings of existing methods, we introduce a novel method called Cancer
Correlation Clustering (C3) to directly tackle the problems of integrating diverse sources of evidence regarding
driver pattern behavior and eliminating computational bottlenecks associated with large cluster sizes or cluster
numbers. C3 uses an optimization framework specifically developed for the driver discovery task, where data is
converted to a simple set of optimization weights that do not require the algorithm to change upon incorporation
of new data sources. In addition to this flexibility, C3 has low computational cost, and it allows for adding
relevant problem constraints while retaining good theoretical performance guarantees.
The paper is organized as follows. A basic introduction of the principles of correlation clustering is provided
in Section 2. Section 3 contains a description of the weight computation methods, the algorithmic clustering
approach based on the computed weights, and the evaluation criteria used to compare C3 and CoMEt. Section 4
contains the main results of our analysis, contrasting the performance of C3 and CoMEt on breast cancer and
glioblastoma data. A discussion of our findings and concluding remarks are given in Section 5. A rigorous
mathematical performance analysis of C3 may be found in the Supplementary Materials.
2 Approach
The basic idea behind the C3 approach is correlation clustering, an agnostic learning technique first proposed
in [3]. In the most basic form of the clustering model, one is given a set of objects and, for all or some pairs of
objects, one is also given an assessment as to whether the objects are “similar” or “dissimilar”. This information
is described using a complete graph with labeled edges: each object is represented by a vertex of the graph, and
the assessments are represented by edges labeled with either a “+” symbol, for similar objects, or a “-” symbol,
for dissimilar objects. The goal is to partition the objects into clusters so that the edges within clusters are
mostly positive and the edges between clusters are mostly negative. Unlike in many other clustering models,
such as k-means [19], the number of clusters is not fixed ahead of time and finding the optimal number of
clusters is part of the problem.
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The similarity assessments need not be mutually consistent: for example, if the graph contains a triangle
with two positive edges and one negative edge, then we must either group the endpoints of the negative edge
together, erroneously putting a negative edge inside a cluster, resulting in a “negative error” or else we must
group them separately, forcing one of the positive edges to erroneously go between clusters, resulting in a
“positive error”. When a perfect clustering is not possible, we seek an optimal clustering: one that minimizes
the total number of “errors.” This form of correlation clustering is known to be NP-hard, but depending on the
graph topology, various constant or logarithmic approximation guarantees exist.
The authors of [3] also proposed a weighted version of the correlation-clustering problem, where the edges
of the graph receive weights between−1 and 1 rather than simply receiving + or− labels: an edge with weight
x incurs cost 1+x2 if it is placed between clusters and cost
1−x
2 if it is placed within a cluster. A more general
weighted formulation was introduced in [7, 8], and this is the formulation we subsequently consider. In this
model, each edge e is assigned two nonnegative weights, w+e and w
−
e . A clustering incurs cost w
+
e if e is placed
between clusters, and incurs cost w−e if e is placed within a cluster.
If no restrictions are placed on the weightsw+e andw
−
e , then it is possible to have edges withw
+
e = w
−
e = 0;
these edges are effectively absent from the graph, so there is no loss of generality in assuming that the graph is a
complete graph. In order to arrive at problems that have efficient constant approximation algorithms, one needs
to place certain restrictions on w+e and w
−
e . The probability constraints give a natural restriction on the edge
weights w+e +w
−
e = 1 for every edge e. Another widely studied restriction is the triangle inequality restriction,
where one requires w−uw ≤ w−uv + w−vw for all distinct vertices u, v and w.
The analytic approach pursued in this work operates on the following model: genes which show sufficiently
large mutation prevalence in cancer patients represent vertices of the complete graph to be clustered. Note that
in this work we only use the top 5% of genes ordered by mutation frequency. This equates to 170 genes in
glioblastoma (GBM) and 130 genes in breast cancer (BRCA). The weights w+e and w
−
e of an edge e connecting
two genes g1 and g2 are weighted sums of the mutual exclusivity and coverage strength, as well as an adequately
chosen measure of network distance and expression similarity.
More precisely, the negative weights w−e are chosen to be relatively small if the endpoint genes describing
the edge are deemed to be mutually exclusive in cancer patients. A small negative weight encourages placing
mutually exclusive genes within the same cluster. The positive weights jointly depend on the coverage, network
distance and expression correlation of the endpoint genes: the larger the joint coverage, co-expression and
inverse of the network distance of the endpoint genes, the more likely they will end up in the same cluster.
Precise mathematical formulations of the weight functions will be provided in the next section.
To control the size of the resulting clusters so as discourage uninformative singleton and giant clusters, we
developed two new correlation clustering algorithms that use cluster sizes as problem parameters that may be
chosen by the users. These cluster size bounds also allow for more accurate comparison with other methods
which operate with inherent cluster size constraints. Notice that unlike in the aforementioned known methods,
the cluster sizes have no bearing on the complexity of our algorithm nor on their overall approximation quality.
The driver discovery approaches closest to C3 are Multi-Dendrix [23] and CoMEt [24]. Multi-Dendrix is
an integer linear programming clustering algorithm that ensures that the genes within a cluster have mutation
patterns that satisfy mutual exclusivity and coverage: for any two genes in a cluster, the number of patients in
which these genes are mutated at the same time is relatively small; in addition, a large portion of the patients
should have at least one mutation in each cluster. CoMEt uses a statistical score of mutation exclusive that
conditions upon the frequency of each alteration, alleviating the inherent bias caused by frequently mutated
genes. Compared to Multi-Dendrix, C3 uses a weighted linear programming relaxation instead of an integer
linear program which significantly improves the versatility and running time of the algorithm. Furthermore,
the weights allow for straightforward incorporation of heterogeneous sources of evidence into the clustering
method and the algorithm itself remains unchanged with the addition of new data. This flexibility comes at the
cost of C3 providing only an approximate solution. Nevertheless, given the inherently approximate nature of
weight selection and parametrization of both algorithms, this does not appear to be a significant shortcoming.
Also, empirical evaluations suggest that the approximation algorithms produce results very close to the optimal
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solution. Another advantage is that if one needs to change the combinatorial conditions that the clusters satisfy,
Multi-Dendrix cannot be easily adapted, and a whole new algorithm needs to be developed. On the other
hand, our algorithms are very flexible and most combinatorial patterns can be easily incorporated in the same
algorithm, by simply changing the weights assigned to the edges.
3 Methods
Before rigorously describing our algorithmic methods, we introduce some relevant notation and explain how to
estimate appropriate clustering weights based on available data.
3.1 Clustering Weights
Let G(V,E) be a complete graph, where V (G) denotes the set of vertices and E(G) denotes the set of edges
of the graph G, respectively. The symbol e ∈ E(G) or e = uv with u, v ∈ V (G) is used to denote a generic
edge. Each edge is assigned a positive weight w+e and a negative weight w
−
e . Recall the interpretation of
these weights: for two distinct vertices u, v ∈ V (G), w+uv is the cost of placing u and v in different clusters;
consequently, by making the positive weight of an edge large, one can discourage placing the corresponding
two genes into different clusters. Similarly, w−uv is the cost of placing u and v in the same cluster, and hence
making this weight large discourages placing the corresponding two genes into the same cluster. In the rest of
this section, we will explore different ways of defining the weights w−uv and w+uv; in order to avoid confusion
between the different definitions, each weight we define will include a parenthetical abbreviation, so that, for
example, w+(c)uv will refer to the positive weight of uv defined according to the coverage criteria, while
w+(c,n)uv will refer to the positive weight of uv according to the coverage and network criteria.
The weights are computed using four types of datasets: gene alteration data, gene copy number variation
(CNV), network information (NI), and gene expression (GE) data. Let np denote the number of samples (i.e.,
patient genomes available) and let ng denote the number of genes. Also, letA ∈ {0, 1}ng×np denote the matrix
containing alteration data: if gene i is altered in sample j, we set A(i, j) = 1; otherwise, we set A(i, j) = 0.
Also, letC be an ng×np matrix representing the CNV data: we setC(i, j) = 0 if there is no change in the copy
number of gene i in sample j; otherwise, we choose an integer value reflecting the deviation of the CNV number
from its baseline value. Hence, the CNV matrix contains both positive and negative values corresponding to
the copy number changes of the corresponding gene in each sample.
To combine the CNV with alteration, we referred to the following method. Using the matrices A and C,
we formed a new binary matrix M ∈ {0, 1}ng×np such that
M(i, j) = 0 if A(i, j) = 0 AND lcnv < C(i, j) < hcnv, (1)
and M(i, j) = 1, otherwise. In this formulation, lcnv and hcnv are lower and upper bounds that may be
chosen by the user. These bounds determine what is deemed to be a significant CNV change. In our tests, we
set lcnv = −1 and hcnv = 3, although other options are clearly possible. It is worth pointing out that more
conservative CNV thresholds tend to decrease coverage, while more relaxed CNV assumptions tend to decrease
mutual exclusivity. Based on the procedure above, we arrive at one “mutation” matrix M which we use instead
of the matrices A and C.
Finally, let Z ∈ Rng×np be the matrix corresponding to z-scores of gene expression data: here, Z(i, j)
denotes the z-score of the expression of gene i in sample j. More precisely, if the raw expression of gene i
in sample j equals xij , then Z(i, j) =
xij−µi
σi
; µi denotes the average expression of gene i and σi denotes its
standard deviation.
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3.1.1 Clustering Weights Determined Based on Mutual Exclusivity and Coverage (ME-CO)
The idea behind our approach is to impose the mutual exclusivity constraint through the weights w−e and
coverage constraint through the weights w+e s.
For each gene (i.e., vertex) u, let S(u) denote the set of patients in which u is mutated. Note that we use
the matrix M to determine if a mutation in the gene exists, either due to sequence alteration or CNV. Then, for
any u, v ∈ V (G), the negative weights are chosen according to
w−(e)u,v = a× |S(u) ∩ S(v)|
min(|S(u)|, |S(v)|) , (2)
where a is a scaling parameter to be chosen by the user. The intuition behind the use of the factor a is that if a
is large (e.g., empirically, a value of a > 3 is deemed large), the mutual exclusivity is enforced strictly, while
if a is small, (e.g. a < 3), the genes in each cluster may not be highly mutually exclusive. Also, note that
0 ≤ |S(u)∩S(v)|min(|S(u)|,|S(v)|) ≤ 1.
To capture the coverage property through the positive weights, observe that if two genes increase the cov-
erage significantly, their positive weight should be large so that they are encouraged to be placed in the same
cluster. To determine the positive weights, we first form the set D = {D(u, v)}, for all u, v ∈ V (G), where
D(u, v) = |S(u) ∆ S(v)| and ∆ denotes the symmetric difference of two sets. A large value for the symmetric
difference D(u, v) suggests that the vertices u and v should be placed in the same cluster, since they increase
the coverage of the cluster.
Given the set D, we define T (J) to be the J th percentile of the values in D. In all our runs, we used the
default value of J = 95, although this choice may be governed by the user as well. The positive weights are
chosen according to:
w+(c)uv =
{
1, if D(u, v) > T (J)
1
T (J) ×D(u, v) otherwise.
(3)
Note that by this definition, 0 ≤ w+(c)e ≤ 1 for any e ∈ E(G).
In order to ensure that the positive and negative weights meet the constraints imposed by our algorithm
needed to ensure a constant approximation guarantee, we require that for all u, v ∈ V (G),w−(e)uv+w+(c)uv ≥
1. This leads to the additional constraints:
if w+(c)uv + w−(e)uv < 1, (4)
set w−(e)uv =
w−uv
w+(c)uv + w−(e)uv
, and w+(c)uv = 1− w−(e)uv.
3.1.2 Clustering Weights Determined Based on Mutual Exclusivity, Coverage, and Network Infor-
mation (NI-ME-CO)
The comprehensive results of pan-cancer studies reported in a number of recent papers (23, 32, 24, 15) have
revealed the important connection between network topology and cancer driver distribution patterns. More pre-
cisely, the effect of deleterious mutations on the phenotype may be suppressed through a particular configuration
of the corresponding protein complexes, and at the same time, the strength of the effect of a mutation may be
emphasized through another configuration. As an example, most of the variants observed in healthy individuals
seem to appear at the periphery of the interactome, and they do not seem to influence network connectivity. In
contrast, cancer driver somatic mutations tend to occur in central, internal regions of the interactome and within
highly co-integrated components. It appears that no previous attempts were made to more precisely quantify
the network distances between driver variants, which prompted us to perform the following analysis. We first
computed the pairwise (shortest) network distances between genes in a large pathway comprising 8, 726 genes
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Figure 1: Histogram of shortest distances between randomly selected genes and driver genes in the network.
from Ciriello et al. [9] via an implementation of the standard Dijkstra algorithm [38]. In this test, we randomly
selected 1, 000 pairs in order to reduce the computational burden of running Dijkstra’s algorithm O(87262)
times. By using the most complete known driver list from the Cancer Gene Census (CGC) [13], we computed
the same distances for driver genes, this time for all pairs of genes. The resulting distribution of shortest paths
is depicted in Fig. 1. One can clearly observe that the average shortest distance between drivers is significantly
smaller than the average shortest distance between two randomly selected genes. A permutation test confirms
this observation, and we calculated a p-value of less than 0.001.
These findings suggest that when determining potential driver mutations, one should make use of network
distance and connectivity information. This may be accomplished in our approach by adjusting the positive
weight of edges connecting two genes: if both endpoint genes were to be drivers, they should be sufficiently
central to a given pathway, close to other drivers or to each other.
For this purpose, we consider an undirected graph corresponding to the gene network, denoted byG′; in this
graph, which is assumed to be known a priori and which in this work was retrieved from the KEGG Database,
each vertex corresponds to a gene. The graph is not complete, but rather relatively sparse, and each edge
represents an interaction between genes. As before, we let np and ng = |V (G)| = |V (G′)| denote the total
number of patients and the total number of genes in our dataset, respectively. For each vertex u ∈ V (G′), we
letN (u) denote the set of neighbors of u and letN ′(u) =N (u)∪{u}. The first step in assigning the positive
weights is to determine the set F = {f(u, v)}, where for any pair of vertices u, v ∈ V (G′),
f(u, v) =
|N ′(u) ∩N ′(v)|
|N ′(u) ∪N ′(v)| . (5)
Note that 0 ≤ f(u, v) ≤ 1 for all u, v. A large value of f(u, v) suggests that the genes u and v are well
connected and likely to be involved in the same pathway [9], and that the corresponding genes should be
clustered together.
Given the set F , we define T ′(J ′) to be the J ′th percentile of the values in F . For any u, v ∈ V (G), the
positive weights are then chosen according to the following formula:
w+(c,n)uv = w1w+(c)uv + w2w+(n)uv, (6)
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where w1, w2 ≥ 0, w1 + w2 = 1, and as before, the coverage weight equals
w+(c)uv =
{
1, if D(u, v) > T (J)
1
T (J) ×D(u, v) otherwise,
(7)
and the network weight equals
w+(n)uv =
{
1, if f(u, v) > T ′(J ′)
1
T ′(J ′) × f(u, v) otherwise.
(8)
Again, in order to ensure that for all u, v ∈ V (G), w−(e)uv +w+(c,n)uv ≥ 1, we add the additional constraints
if w+(c,n)uv + w−(e)uv < 1, (9)
set w−(e)uv =
w−(e)uv
w+(c,n)uv + w−(e)uv
, and w+(c,n)uv = 1− w−(e)uv.
The weights w1, w2 may be chosen in such a way as to emphasize the importance of either coverage or network
information. We suggest using w1 = w2 = 1/2 in a coverage/network only test, although our analysis reveals
that emphasizing one criterion over the other offers improved algorithm performance on some datasets.
3.1.3 Clustering Weights Determined Based on Mutual Exclusivity, Coverage, and Gene Expression
Data (EX-ME-CO)
Similar to the case of network information, expression data may be incorporated through the positive weights,
using the assumption that coexpressed genes may be involved in the same function or cancer pathway. Hence,
highly coexpressed genes should be encouraged to cluster together.
To explain how to incorporate gene expression data into the clustering procedure, assume that z(u) and
z(v) denote the vectors of time-evolving expression values corresponding to genes u and v, respectively. The
first step in assigning the positive weights is to determine the set G = {g(u, v)}, where for every pair of genes
u, v,
g(u, v) =
|〈z(u), z(v)〉|
||z(u)|| ||z(v)|| . (10)
Here, 〈a,b〉 denotes the classical inner product of the vectors a and b, while ||a|| stands for the `2 norm. A
large value for g(u, v) indicates that the expression vectors of u and v are highly correlated and hence should
be clustered together. Also, note that 0 ≤ g(u, v) ≤ 1 for all u and v.
Given the set G, we let T ′′(J ′′) denote the J ′′th percentile of the values in G. For any u, v ∈ V (G), the
positive weights are chosen according to the following formula:
w+(c,x)uv = w1w+(c)uv + w2w+(x)uv, (11)
where w1, w2 ≥ 0, w1 + w2 = 1, and
w+(c)uv =
{
1, if D(u, v) > T (J)
1
T (J) ×D(u, v) otherwise,
(12)
and
w+(x)uv =
{
1, if g(u, v) > T ′′(J ′′)
1
T ′′(J ′′) × g(u, v) otherwise.
(13)
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Hence, all the conditions are satisfied for the weights, except possibly the third one. In order to make sure that
for all u, v ∈ V (G), w−(e)uv + w+(c,x)uv ≥ 1, we include an additional condition that
if w+(c,x)uv + w−(e)uv < 1, (14)
setw−(e)uv =
w−(e)uv
w+(c,x)uv + w−(e)uv
, andw+(c,x)uv = 1− w−(e)uv.
Note that other combinations of datasets may be used, with appropriate changes in the weights. For exam-
ple, incorporating coverage, network information as well as expression information into a positive weight may
be accomplished by setting
w+(c,n,x)uv = w1w+(c)uv + w2w+(n)uv + w3w+(x)uv, (15)
where w1, w2, w3 ≥ 0, w1 + w2 + w3 = 1.
3.2 Clustering Algorithms
The bounded cluster size correlation clustering problem for driver gene inference may be formulated as follows.
Let K be a “hard” bound on the size of the driver clusters, and let the positive w+ and negative weights w−
be chosen according to a desired combination of datasets, as described in the previous section. The optimum
clustering may be found by solving the integer linear program (ILP) below.
minimize
x
∑
e∈E(G)
(w+e xe + w
−
e (1− xe)) (16)
subject to xuv ≤ xuz + xzv (for all distinct u, v, z ∈ V (G)) (17)∑
v 6=u
(1− xuv) ≤ K (for all u ∈ V (G)) (18)
xe ∈ {0, 1} (for all e ∈ E(G)). (19)
In this formulation, and for a fixed edge e = uv, xuv = 1 implies that u and v should belong to different
clusters and xuv = 0 implies that the two vertices should belong to the same cluster. Note that the triangle
inequality (17) ensures that if u and z are in the same cluster and z and v are in the same cluster, then u and v
are also in the same cluster. Any clustering of the vertices can be described using the variables xe. For a fixed
clustering, the objective function is the cost associated with that clustering.
Solving the ILP is NP-hard. We hence relax the problem by changing the integer constraint xe ∈ {0, 1}
to an interval constraint xe ∈ [0, 1]. This relaxation leads to a classical LP, the solution of which may be frac-
tional. To obtain a valid clustering, the fractional solutions have to be subsequently rounded to produce integer
solutions. Unfortunately, known rounding algorithms (33) for this problem tend to produce small clusters, often
as small as single-vertex clusters. For our study, we hence slightly modify the LP by removing the cluster size
constraint (19), which we move directly to the rounding procedure as described in Algorithm 1.
Algorithm 1 is closely based on the rounding algorithm described in Charikar et al. [7, 8]. The idea behind
the rounding algorithm is to pivot on one vertex, examine its closest neighbors, where closeness is governed
by the value of the output variables xe of the LP, and partition large neighborhoods if needed to get clusters
of size at most K + 1. In the Appendix of the Supplementary Materials, we prove that the LP and Rounding
Algorithm 1 provides a 9-approximation for the ILP problem, given that the parameter α is set to 2/7 and given
that the weights obey the following constraints:
• w+e ≤ 1 for every edge e, and
• w+e + w−e ≥ 1 for every edge e.
The above inequalities were addressed in the weight selection process through normalization, as described in
the previous section.
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Algorithm 1
Input: {xe}e∈E(G), α and K
Let S = V (G).
while S 6= ∅ do
Let the “pivot vertex” u be an arbitrary element of S.
Let T = {w ∈ S − {u} : xuw ≤ α}.
if
∑
w∈T xuw ≥ α |T | /2 then
Output the singleton cluster {u}.
Let S = S − {u}.
else if |T | ≤ K then
Output the cluster {u} ∪ T .
Let S = S − ({u} ∪ T ).
else
Partition T as T = T ′0 ∪ T1 ∪ · · · ∪ Tp, where |T ′0| = K and each |Ti| = K + 1 for 0 < i < p and
|Tp| ≤ K + 1.
Let T0 = {u} ∪ T ′0.
Output the clusters T0, T1, T2, . . . , Tp.
Let S = S − ({u} ∪ T ).
end if
end while
3.3 Evaluation methods
We evaluated the performance of both C3 and CoMEt in terms of their ability to detect mutually exclusive,
high-coverage, and biologically relevant gene clusters. We ran both methods using mutation and CNV data
collected from TCGA, pertaining to breast cancer (BRCA) [28] and glioblastoma (GBM) [5]. In addition to
GBM and BRCA, we also considered kidney cancer (KIRC) and ovarian cancer (OV), but the available patient
data appeared limited at this stage to allow for statistically significant and comprehensive results. We accessed
the TCGA provisional data using the cBioPortal platform [14] on August 14, 2015. We ran both methods using
the same alteration dataset. We evaluated both point mutations and indels, and for CNVs, we used the GISTIC
thresholds [27] of -1 and 3 as our cut-offs. To focus on mutations with high frequency, we only selected genes
in the top 95 percentile of alteration frequencies, thereby obtaining 130 genes spanning 959 patient samples in
BRCA and 170 genes spanning 291 patient samples in GBM.
To test the effects of cluster sizes and the quality of our results, we ran both C3 and CoMEt to find clusters
of sizes upper bounded by 5, 6, 7, 10, and 15. CoMEt is naturally designed to discover the “most” mutually
exclusive gene sets. Due to the fact that correlation clustering will cluster all genes in a dataset, we only
compared the top ten most mutually exclusive gene sets generated by C3 with those of CoMEt.
We ran CoMEt with 1, 000 iterations each and 3 initialization points to ensure both timely and consistent
runs. For C3, we ran the C3 clustering method for all combinations of weightsw1, w2, w3 ∈ {0, 0.25, 0.5, 0.75, 1}
that satisfy w1 +w2 +w3 = 1, but selected to report only results for the weight parameters w1 = 0.167 (cover-
age), w2 = 0.333 (network information) and w3 = 0.333 (expression data). We observe that the choice of the
weights may be completely governed by the user, and that the increase in one weight may produce better results
in one performance category while reducing the performance in another category. Our choice of high weights
for expression and network information was governed by the need to increase the ability of the C3 algorithm
to detect biologically significant clusters. Furthermore, the patient coverage criteria appears to be less relevant
than pathway coverage and some other coverage properties that have not been explicitly investigated in the
literature. We used four statistical methods to assess the performance of the algorithms which reflect both the
statistical and biological significance of the clusters found.
Mutual Exclusivity. To evaluate the degree of mutual exclusivity in a cluster, we performed a Fisher Exact
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Test [12] for each pair of genes in the cluster. The Fisher Exact Test uses the hypergeometric distribution to
calculate the probability of observing a 2 × 2 contingency table of n total samples, with a samples that has an
alteration in two genes (say, gi and gj), b samples with an alteration in gene gi only, and c samples with an
alteration in gene gj only. If d is the number of samples with no alteration in either gene, then the probability
of co-mutation is evaluated according to
P (gi, gj) =
(
a+b
a
)(
c+d
c
)(
n
a+c
) (20)
We evaluated the overall exclusivity of a cluster as the median value of each pairwise test for each pair of genes
gi, gj in the network. The pairwise Fisher’s method has also been used by Mutex suite to establish mutual
exclusivity [2]. However, because in our context the Fisher Exact Test is used as an evaluation rather than
discovery tool, we used the median pairwise p-value rather than the maximum p-value to get a better sense of
the overall exclusivity of genes in a cluster. It is also important to note that while CoMEt has an built-in method
that generalizes the exclusivity test to 2k contingency table for a cluster size k, the exponential size of their test
set makes evaluation for large cluster sizes computationally impractical. An alternative test for overall mutual
exclusivity is a permutation test, as implemented by MEMo, which compares the exclusivity of a gene set by
sampling random gene sets and comparing the patients with multiple alterations.
Coverage. To compare and evaluate the overall coverage of a cluster found by C3 or CoMEt, we calculated
the proportion of patients with at least one alteration in a gene belonging to the given cluster.
Network Clustering. We also performed a pathway analysis for the potential drivers. As pointed out in the
previous section, driver genes tend to be, on average, closer to each other in a pathway compared to randomly
selected genes. Using this dogma, we calculated the average pairwise distance between each each pair of genes
gi, gj within a discovered cluster using Dijkstra’s Algorithm. As before, our tests were performed on 8726
genes from [9].
Biological Significance. In addition to testing the performance of the algorithm with respect to mutual
exclusivity and coverage, we also investigated the biological significance of the C3 and CoMEt methods from
the perspective of gene discovery and pathway analysis. Although there is no overarching gold standard to
determine biological significance, a commonly accepted metric employed by MEMo, Dendrix, Mutex, CoMEt
and other similar tools is to count the number of known driver genes found within the best clusters according
to the mutual exclusivity principle. These clusters usually contain several known driver genes. To determine
the driver gene-based biological significance, we calculated the proportion of drivers found in the ten most
mutually-exclusive C3 and CoMEt clusters using a comprehensive, curated list of known drivers from the
Cancer Gene Census [13].
It is important to point out that while the four benchmarks we define are a reliable way to test the per-
formance of CoMEt and C3, no perfect benchmark exists for detecting mutually exclusive and biologically
significant genes clusters. As with many previous methods regarding this topic, the criteria are in a sense circu-
lar in that some of the same parameters that we maximize are the parameters that we use to evaluate the method.
This is the reason why we use multiple benchmarks to evaluate the method.
4 Results
In what follows, we demonstrate that C3 outperforms CoMEt in almost all of the aforementioned benchmarking
criteria. As a rule of thumb, C3 can be made to outperform CoMEt in any chosen single criteria or pairs of
criteria by adjusting the weights appropriately. This observation follows from that fact that the weights trade
off the strengths of different modeling assumptions. We supplement our statistical analysis with a discussion
of the biological relevance of our findings, and explore the role of the new potential drivers found by C3 within
their driver gene communities. In particular, we discuss the significance of large mutually exclusive clusters
that cannot be recovered by other methods. Recall that we restrict our attention to the ten best performing
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Figure 2: A comparative analysis of C3 (Red) and CoMEt (Blue) based on four evaluation criteria. We used five cluster
sizes (5, 6, 7, 10, and 15) that index the x-axis in each benchmark test. (A) depicts the results based on the driver gene
evaluation criteria. The y-axis represents the proportion of drivers found by each method, contained within the best
ten clusters found. The purple line represents the expected value of drivers detected if clusters are randomly selected.
(B) shows the pairwise mutual exclusivity of each run. The y-axis represents the negative log transform of the mutual
exclusive p-value such that larger values are more mutually exclusive than smaller ones. The boxplots illustrate the
distribution of exclusivity results concerning each of the top ten individual clusters for C3 and CoMEt. (C) shows the
distribution of coverage, measured by proportion of samples with at least one alteration in a given cluster (the y-axis).
The boxplot illustrates the distribution of coverage results for individual top ten cluster results. (D) includes the network
connectivity results of C3 and CoMEt. The y-axis measures the average pairwise network distance between all genes
in a cluster, and the distribution of each cluster is shown in the boxplot. The purple line represents the average pairwise
distance of random clusters.
clusters according to mutual exclusivity, as this approach was used in the original evaluation process of the
CoMEt algorithm.
4.1 Performance evaluation
The results of our extensive comparison between C3 and CoMEt, regarding mutual exclusivity, coverage, driver
identification, and pathway-level evaluation, are shown in Fig. 2. Both algorithms were tested on the same
server with a 256GB RAM memory. Both methods ran uninterruptedly when the cluster sizes were constrained
to k = 5, 6, 7, and 10. CoMet reported segfault memory errors for k = 15, and for this case, only C3 was
benchmarked.
To assess the biological significance of the two methods in terms of their ability to cluster high-impact
drivers from the CGC repository together, we compared the results of C3 and CoMEt both to each other and to
a “baseline” value equal to the average proportion of drivers in the ten most mutually-exclusive clusters found,
in this case 0.067, using uniform random sampling of genes (see Fig. 2A). In BRCA, we found that C3 detected
a median driver proportion of 0.160 and CoMEt detected a median driver proportion of 0.117 in the top ten
clusters. C3 outperforms CoMEt for each cluster size. We also used a Mann-Whitney Rank Sum test (34)
to compare the overall performance of the algorithms with respect to mutual exclusivity, for all cluster sizes.
We chose a rank-sum test because it is unclear that the drivers are following a normal distribution due to the
small amount of data available. The results show that C3 outperforms CoMEt (p-value of 0.0079) in terms of
amount of drivers in clusters. C3 also outperforms CoMEt on GBM, with a median proportion of drivers per
cluster equal to 0.170, compared to a 0.12 proportion of drivers per cluster found by CoMEt. This finding holds
for every cluster size, with a rank-sum test p-value of 0.0361. Both methods succeed in finding biologically
significant drivers within clusters exhibiting high mutual exclusivity, and both methods significantly outperform
11
the expected number of drivers per cluster in the random setting (p-value 1.594×10−5 and p-value 1.312×10−3
for C3 and CoMEt, respectively).
We next tested the clusters found by each method based on their mutual exclusivity (see Fig. 2B). To do so,
we used the previously described pairwise Fisher’s exact test to obtain a p-value for each of the top ten clusters
of the two methods. For better visualization, we performed a negative log transform on the p-values, and plotted
the transformed p-value distribution. Hence, in this system, larger values indicate more mutually exclusivity.
We again used a Mann-Whitney rank-sum test to evaluate the performance of C3 and CoMEt. For BRCA, one
can see that while both methods have significant median exclusivity values (p = 7.541 × 10−6 for C3 and
p = 3.337 × 10−4 for CoMEt), C3 has an overall more significant p-values for each cluster size. The median
p-value of C3 for each cluster size is lower than its CoMEt counterpart except for the case k = 10. However, C3
does have superior performance overall with a rank-sum p-value of p = 4.0202× 10−4. For GBM, the median
exclusivity results are not as strong as for the BRCA set, for both the C3 and CoMEt method. C3 has a median
p-value of 0.3795 as opposed to CoMEt’s 0.5022. The general drop in significance may be attributed to a lower
confidence of the Fisher test due to a small number of samples available; recall that the GBM set involved
291 samples, compared to 959 BRCA samples. This indicates that one should look at individual significant
clusters to evaluate mutual exclusivity. Even for the reduced median p-value regime, C3 outperforms CoMEt
in significance, having lower median p-values for each cluster size. Overall, the C3 p-values are consistently
and significantly lower than those produced by CoMEt for mutual exclusivity (the rank-sum test p-value equals
0.04401).
The results of the coverage tests are depicted in Fig. 2C. In the coverage benchmark, CoMEt outperforms
C3 for GBM, but neither method outperforms the other BRCA. In BRCA, both methods show comparable
performance, with a median result for the fraction of samples covered equal to 0.5505 for C3, and 0.5662
for CoMEt. This rather poor performance of both methods is observed for all values of k, with no p-value
based on a Student T-test 43 being less than 0.05. The largest difference in coverage recorded for the two
methods is present for k = 6. In conclusion, there appears to be no statistical difference between C3 and
CoMEt in terms of BRCA coverage percentage (p-value of 0.5127). In GBM, the median p-value for coverage
difference is more pronounced. The median coverage of C3 is 0.632 and the median coverage of CoMEt is
0.696. CoMEt finds significantly higher-coverage clusters according to the Student T-test, with p-value 0.0345,
and the most pronounced coverage percentage differences exist for small values of k (0.3745 vs. 0.6495 for
k = 5 C3 and CoMEt, respectively). It is also important to note the wide distribution of coverage score values
produced by C3 for small k: the IQR (Interquartile range) value is roughly 0.35 for k = 5. The most likely
reason behind this result is that our test weights were chosen to boost the relevance of mutual-exclusivity and
biological significance rather than coverage. Mutual exclusivity accounts for 100% of the negative weights
of edges, while coverage accounts for only 16.7% of the positive weights. We justify this weight choice by
the fact that it leads to multiple significant cluster discovery and by our belief that coverage is a less significant
driver property compared to mutual exclusivity. We also emphasize that a potentially biologically more relevant
coverage constraint should pertain to important pathway, rather than patient sample coverage.
As already mentioned in the previous sections, one advantage of C3 is that the user can adjust the weights
according to her/his own belief about the significance of patient coverage. For example, by changing the
averaging weights in our GBM run tow1 = 0.60 (coverage),w2 = 0.20 (network), andw3 = 0.20 (expression),
we obtain a coverage percentage of 0.7903 for k = 5. However, this excellent coverage comes at a cost of a
less significant mutual exclusivity score (fractional value 0.4288) and a lower proportion of detected drivers
(fractional value 0.1267). As may be seen from the above example, C3 is highly customizable and can be
adapted to the user’s specification to best reflect the scope and preferences of the analysis.
The last setting in which we analyzed C3 and CoMEt uses the distances of drivers in the network as per-
formance criteria (see Fig. 2D). Here, we calculated the average pairwise distance between all pairs of genes
clustered together. We used the Student T-test to determine the statistical significance of this value. We also
compared the values for both algorithms based on 1000 randomly selected genes by using a permutation test.
For BRCA, we found no significant performance difference between the two methods in terms of the average
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pairwise distance: 3.110 for C3 and 3.070 for CoMEt, with a p-value of 0.9330. In GBM, C3 showed a smaller
average pairwise distance of 2.908 compared to CoMEt’s 3.097. This difference is statistically significant, with
a p-value of 0.0379. The small average network distance results of C3 for GBM, coupled with the low coverage,
leads to the conclusion that C3 favors niche, exclusive clusters in biologically relevant cancer pathways. Hence,
the method may be useful for discovering specific molecular cancer subtypes. Both methods had an average
pairwise distance well below the permutation benchmark of 3.903: the p-values of both C3 and CoMEt were
less than 2× 10−16 for each cancer type.
In conclusion, from our detailed evaluation we conclude that although C3 does not outperform CoMEt with
respect to all four evaluation criteria, but only three of them, the C3 performance indicates a strong overall
propensity to select biologically more relevant and mutually exclusive clusters, and with a higher degree of
flexibility compared to CoMEt.
4.2 Discovering potential driver pathways
We examine next the potential of the C3 algorithm to detect clusters whose genes may be novel cancer driver
candidates. We focus our search on clusters that contain biologically significant driver genes and known bio-
logical network interactions, and exhibit high mutual exclusivity and coverage. We also focused on the large
cluster size regime, as results in this domain have not been previously reported in the literature. Two examples
are shown in Fig. 3 and Fig. 4.
In BRCA, one candidate cluster with several potential novel driver genes is the cluster containing PTEN,
HUWE1, CNTNAP2, GRID2, CACNA1B, CYSLTR2, MYH1 depicted in Fig. 3. The genes in the candidate clus-
ter are mutually exclusive (p-value = 0.0084). The genome landscape of this cluster is dominated primarily
by mutations in PTEN and HUWE1, and secondarily by homozygous deletions in PTEN and CYSLTR2. The
most frequently altered gene in this set is a common driver gene PTEN, a tumor suppressor gene that negatively
regulates the AKT/PKB apoptosis pathway [39]. The remaining six genes in the cluster are potential driver
candidates. HUWE1 is a part of the Mule multidomain complex of the HECT domain family of E3 ubiquitin
ligases responsible for apoptosis suppression, DNA damage repair, and transcriptional regulation [21]. CNT-
NAP2 is a neurexin protein with functions in cell-to-cell adhesion and epidermal growth factor and was found
to be hypomethylated in breast cancer cell lines [37]. Hypomethylation and the association with epidermal
growth factors, coupled with a large number of amplifications in the alteration landscape of CNTNAP2 suggest
potential oncogenic functions of the gene. GRID2 is an ionotropic glutamate receptor that is frequently deleted
in lymphomas [35]. CACNA1B codes for a N-type calcium channel which is responsible for calcium influx.
Defects in the calcium influx channel can lead to alteration in the apoptosis, proliferation, migration and inva-
sion pathways of breast cancer [1]. CYSLTR2 is a proinflammatory cysteinyl leukotriene receptor that plays a
role in cancer cell differentiation and is associated with breast cancer survival rates [25]. MYH1 is a myosin
heavy chain protein that plays a role in cell signaling and pro-apotosis pathways.
Perhaps more important than the propensity of each individual gene to be a driver is the collective interaction
pattern of the seven genes in the cluster in a cancer pathway. From Fig. 3, it is clear that the each gene in
the cluster interacts with each other in a tightly-connected community with no gene more than three nodes
away when plotted in the network, using the cBioPortal visualization tool. The seven genes in the cluster
PTEN, HUWE1, CNTNAP2, GRID2, CACNA1B, CYSLTR2, MYH1 are strong candidates to define a novel
driver pathway. This conclusion is reinforced by the presence of high impact common drivers (TP53, MYC,
AKT, and PIK3R1) which define several important cancer pathways such as apoptosis, DNA repair, and cell
cycle arrest [40, 42].
We also examined a cluster containing potential cancer drivers relevant for GBM. In GBM, we found a
cluster of size 10 with four known drivers and many potential drivers. The cluster includes GLI1, WNT2, BRAF,
PLCG1, FAS, CREBBP, BRCA2, GLI2, PIK3R5, VAMP3 (see Fig. 4). This large cluster has a p-value of 0.0901
in terms of mutual exclusivity, which is actually low as compared to other GBM clusters. The cluster also
contains several important driver genes such as WNT2, BRAF, BRCA2 and CREBBP which encompass pathways
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Figure 3: A cluster of potential driver genes inferred from BRCA. (A) shows the alteration landscape of the cluster,
with blue representing mutation events, red representing copy number deletions, and green representing copy number
amplifications. (B) represents a known subnetwork which contains 6 genes (out of 7) in (A). The more intense the red,
the higher the alteration frequency of the gene. Nodes highlighted in black represent driver candidates identified by C3
within a small subnetwork. Edges are depicted in black if there exists a direct interaction between two genes. Green
edges represent an interaction that undergoes a protein state change. Purple edges are other interactions.
such as sonic hedgehog signaling, cell fate determination, cell growth and apoptosis, checkpoint activation, and
DNA repair. Additionally, six out of the ten members are within the same compact network community (GLI1,
PLCG1, FAS, CREBBP, BRCA2, PIK3R5). Of these six genes, GLI1 and GLI2 are hedgehog signaling genes
that are common and first isolated in glioblastoma. These genes are responsible for cell differentiation and stem
cell self-renewal [10]. PLCG1 is involved in intracellular transduction of receptor-mediated tyrosine kinase
activators, and it has been classified as a biomarker in GBM [36]. FAS is a cell surface receptor that mediates
apoptosis. FAS is known as a histological hallmark of GBM, affecting both apoptosis and necrosis factors [17].
Finally, PIK3R5 is a subunit of phosphatidylinositol 3-kinases who together have important effects on cell
growth, proliferation, differentiation, motility, survival and intracellular trafficking.
5 Discussion and Conclusion
We described a novel method, termed C3, which has the potential to precisely and efficiently identify clusters of
gene modules with mutually exclusive mutation patterns. The C3 algorithm uses large-scale cancer genomics
datasets which are pre-processed to yield parameters governing novel constrained correlation clustering tech-
niques. The optimization criteria used in clustering include patterns of mutual exclusivity of mutations, patient
sample coverage, and network driver concentration.
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Figure 4: A cluster of potential driver genes inferred from GBM. (A) shows the alteration landscape of the cluster,
with blue representing mutation events, red representing copy number deletions, and green representing copy number
amplifications. (B) represents a known subnetwork which contains 6 genes (out of 10) in (A). The more intense the red,
the higher the alteration frequency of the gene. Nodes highlighted in black represent driver candidates identified by C3
within a small subnetwork. Edges are depicted in black if there exists a direct interaction between two genes. Green
edges represent an interaction that undergoes a protein state change. Purple edges are other interactions.
15
There are several major advancements of our method when compared to previously known approaches.
Unlike methods that use randomized approaches without the guarantee that multiple runs of the methods on the
same data will produce compatible results (such as CoMEt), C3 is consistent. Also, C3 has a complexity that
does not depend on the chosen cluster sizes, and is hence much more appropriate for large cluster problems
than other methods. Furthermore, it partitions the gene set and hence creates clusters covering all genes used
in the analysis. This is to be contrasted with the results produced by other methods that tend to identify only a
small number of modules with limited number of genes.
None of the previous methods were able to identify clusters utilizing different sources of information via a
weighting mechanism. This is important because it gives us flexibility to focus more on certain aspects based
on the analysis. For example, we can focus more on mutual exclusivity instead of coverage to identify clusters
specific to a group of samples which may facilitate the discovery of subtype-specific modules.
By addressing the above challenges, we believe our new method C3 represents a unique tool to efficiently
and reliably identify mutation patterns and driver pathways in large-scale cancer genomics studies.
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Supplement – Theoretical Performance Guarantees and Synthetic Data Evaluations
Suppose that we have a weighted correlation-clustering instance, where each edge e incurs a cost w−e if it is
placed within a cluster and incurs a cost w+e if it is placed between clusters. We also assume that each cluster
may contain at most K + 1 vertices, where K is a fixed constant. If no constraint on the size of the clusters is
desired, one can simply set K = |V |.
We wish to find an approximation of the minimum-cost clustering. As already mentioned in the Approach
Section, the C3 method may not work for fully general weights, and, due to the integrality gap in the general
case, no algorithm based on LP rounding can work in the fully general weight case. We therefore require the
following weight constraints:
• w+e ≤ 1 for every edge e, and
• w+e + w−e ≥ 1 for every edge e.
Note that these constraints are satisfied if the weights obey the probability constraints w+e + w
−
e = 1 for all e,
but they also apply to much more general choices of weights, which is relevant for the clustering problem at
hand.
Recall that we adopted the convention that xuu = 0 for all u.We also observe that one can think of the
quantity xuv as a “distance” between u and v. Before starting the analysis of our algorithm, we record an
observation based on the triangle inequality:
Observation 1. Let x be a feasible LP solution, and let wz be an edge. For any vertex u, we have xwz ≥
xuz − xuw and 1− xwz ≥ 1− xuz − xuw.
Given any feasible solution x to the linear program, we use the size-bounded clustering C generated via
Algorithm 1, which we express in terms of a parameter α whose optimal value will be determined later in the
proof. The idea behind the rounding is to use classical rounding to obtain a solution to the non-size-bounded
problem, and if overlarge clusters are produced, to partition them into small-sized clusters.
The standard rounding algorithm comes with a guarantee that cost(C) ≤ 6 cost(x). Here, we cannot ask
for such a guarantee: it is possible, for example, that cost(x) = 0 and cost(C) > 0, if all input edges are
positive but there are too many vertices to fit into a single cluster. Instead, we prove our approximation ratio by
bounding cost(C) in terms of a different lower bound on the cost of an optimal size-bounded clustering.
Let C1 = cost(x). Choose Y ⊆ E(G) to minimize
∑
e∈Y w
+
e subject to the constraint that each vertex v
has at most K incident edges which do not lie in Y . Let C2 =
∑
e∈Y w
+
e . We think of C2 as a lower bound on
positive weight that must be cut in order to produce a clustering with all clusters of size at mostK+1, since the
edges contained within clusters form a subgraph of maximum degree at most K. Thus, the cost of an optimal
size-bounded clustering is at least max{C1, C2}. In particular, an optimal clustering costs at least 79C1 + 29C2.
We will use the following lower bound on C2:
Definition 1. For v ∈ V (G), the excess weight at v, written e(v), is defined by
e(v) = min{
∑
z∈S
w+vz : S ⊆ N(v) and |N(v)− S| ≤ K}.
Lemma 1. C2 ≥ 12
∑
v∈V (G) e(v).
Proof. Choose Y as described above. We have
C2 =
∑
e∈Y
w+e =
1
2
∑
v∈V (G)
∑
vz∈Y
w+vz ≥
1
2
∑
v∈V (G)
e(v),
where the second equality follows from the fact that each edge of Y is counted once at each of its endpoints.
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We use the “charging” idea in rounding, where one can make “charges” both against the individual contri-
bution of each edge, as well as a global “bank” that will be paid for using C2.
Case 1: A singleton cluster {u} is output. The total cluster cost when outputting a singleton cluster {u} is∑
v∈S−uw
+
uv, while the total LP cost accrued by edges incident to u is
∑
v∈S−uw
+
uvxuv.
If the singleton {u} is output, then we have∑
v∈T
xuv ≥ α |T |
2
,
since either the average in step 3 was “too high”, or else T was empty. Now for each v ∈ T we have xuv ≤ α.
For such xuv we have 1− xuv ≥ xuv, since α < 1/2. This yields the following lower bound on the LP cost of
uv:
w+uvxuv + w
−
uv(1− xuv) ≥ w+uvxuv + w−uvxuv ≥ xuv,
where the last inequality uses the bound w+uv + w
−
uv ≥ 1. Thus, each edge uv has LP cost at least xuv, and
so the edges joining u and T have total LP cost at least α |T | /2. Each such edge uv incurs cluster-cost w+uv,
which is at most 1. Thus, charging (2/α)xuv to each edge uv for v ∈ T gives enough charge to pay for the
cluster-cost of edges with v ∈ T , while each edge is charged at most 2/α times its LP cost.
For v ∈ S − (T ∪ {u}), we have xuv > α, so each edge uv incurs LP cost at least αw+uv and incurs cluster
cost at most w+uv. Thus, charging such each edge (1/α)w
+
uvxuv pays for the cluster cost of these edges.
Case 2: A nonsingleton cluster {u}∪T is output. We first consider edges inside {u}∪T , then we consider
edges joining {u} ∪ T with S − ({u} ∪ T ). Finally, we consider edges joining Ti with Tj for i 6= j.
Edges within {u} ∪ T . Suppose vz is an edge contained in {u} ∪ T , so that vz incurs cluster-cost w−vz and
LP-cost at least w−vz(1−xvz). By the definition of T , we have xuv, vuz ≤ α. Hence, by Observation 1, we have
1−xvz ≥ 1−xuv−xvz ≥ 1−2α. Thus, charging 11−2αw−vz(1−xvz) to these edges pays for their cluster-cost.
Edges joining {u}∪T with S−({u}∪T ). Let z be a vertex outside {u}∪T . A cross-edge for z is an edge
from z to {u} ∪ T . We show that the cross-edges for z have total cluster-cost that is at most max{ 11−2α , 2α}
times their total LP-cost. Note that whenever vz is a cross-edge, we have xuv ≤ α, by the definition of T . Each
cross-edge incurs vz cluster-cost w+vz and LP-cost w
+
vzxvz + w
−
vz(1− xvz).
If in fact xuz ≥ 1−α, then Observation 1 yields xvz ≥ xuz−xuv ≥ 1−2α for every cross-edge v, yielding
LP-cost at least 11−2αw
+
vz; thus, such edges have cluster-cost at most
1
1−2α times their LP cost.
It remains to handle the case xuz ∈ (α, 1 − α). Here, we seek a lower bound on the total LP-cost of the
cross-edges for z. Note that the total cluster cost of these edges is
∑
v∈{u}∪T w
+
vz , which is at most |T | since
each w+vz ≤ 1.
By Observation 1, we have xvz ≥ xuz −xuv and 1−xvz ≥ 1−xuz −xuv for each edge vz. It follows that
the total LP-weight of the cross-edges for z is at least∑
v∈{u}∪T
[
w+vz(xuz − xuv) + w−vz(1− xuz − xuv)
]
,
which rearranges to ∑
v∈{u}∪T
[
w+vzxuz + w
−
vz(1− xuz)
]− ∑
v∈{u}∪T
[
(w+vz + w
−
vz)xuv
]
Using the bounds
∑
v∈{u}∪T xuv ≤ α(|T | + 1)/2 and xuv ≤ α for v ∈ T , we bound the subtracted sum as
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follows: ∑
v∈{u}∪T
[
(w+vz + w
−
vz)xuv
]
=
∑
v∈{u}∪T
xuv +
∑
v∈{u}∪T
[
(w+vz + w
−
vz − 1)xuv
]
≤ α(|T |+ 1)
2
+
∑
v∈{u}∪T
[
(w+vz + w
−
vz − 1)xuv
]
=
∑
v∈{u}∪T
[
(w+vz + w
−
vz − 1)xuv +
α
2
]
≤
∑
v∈{u}∪T
[
α(w+vz + w
−
vz)−
α
2
]
.
Note that in the last inequality we rely on the fact that w+vz +w
−
vz ≥ 1. It follows that the total LP cost is at least∑
v∈{u}∪T
[
w+vzxuz + w
−
vz(1− xuz)− α(w+vz + w−vz) +
α
2
]
.
a linear function in xuz . We consider the behavior of this function on the interval (α, 1− α).
When xuz = α, the lower bound simplifies to∑
v∈{u}∪T
[
αw+vz + (1− α)w−vz − α(w+vz + w−vz) +
α
2
]
,
which is at least α(|T |+ 1)/2 since α < 1/2 implies (1− α)w−vz ≥ αw−vz .
When xuz = 1− α, the lower bound simplifies to∑
v∈{u}∪T
[
(1− α)w+vz + αw−vz − α(w+vz + w−vz) +
α
2
]
,
which is again at least α(|T |+ 1)/2 since (1− α)w+vz ≥ αw+vz .
Thus, when xuz ∈ (α, 1 − α), we conclude that the total cluster-cost of the cross-edges for z is at most
2/α times the total LP-cost of those edges. In all cases, charging max{ 11−2α , 2α} times the LP-cost of the edges
pays for their cluster-cost.
Edges joining Ti with Tj for i 6= j. These are the trickiest edges to deal with. The problem is that these
edges may have low LP-cost and high cluster-cost, so we cannot just charge these edges to pay for their cluster
cost. Instead, we will charge edges inside the Ti, and we will charge against the bank.
Let v ∈ Ti. A cross-edge for v is an edge vw with w ∈ Tj for j 6= i. Note that every edge joining Ti, Tj
with i 6= j has at least one endpoint that does not lie in Tp; as such, we will assume that v /∈ Tp.
Define quantities Av and Bv as follows:
Av =
∑
{w+e : e is a crossing edge for v},
Bv =
∑
{w−vz : z ∈ Ti − v}.
Since |Ti| = K + 1, we have∑
z∈N(v)
w+e ≥ Av +
∑
z∈Ti−v
w+vz ≥ Av +
∑
z∈Ti−v
(1− w−vz)
= Av + (K −Bv),
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where the second inequality follows from w+vz + w
−
vz ≥ 1 and the final equality follows from the fact that
|Ti| = K + 1 for i < p. On the other hand, since each w+e ≤ 1, we have
e(v) ≥
 ∑
z∈N(v)
w+e
−K ≥ Av −Bv.
We charge the quantity e(v) to the bank, and we charge w−vz to each edge vz with z ∈ Ti. This yields total
charge at least Av, which is the total cluster-cost of the cross-edges for v. Note that for each edge vz charged
this way, Observation 1 yields 1− xvz ≥ 1− xuv − xvz ≥ 1− 2α. Hence, v charges the edge vz at most 11−2α
times its LP-cost. Observe that each edge in T is only charged this way at its endpoints. (Furthermore, edges
whose endpoints lie in different Ti, Tj with both i, j < p are actually paid for twice.)
In total, we have paid for all the cluster-costs by making the following charges:
• Edges vz within each cluster Ti were charged at most 11−2αw−vz(1 − xvz) to pay for themselves plus at
most 21−2α to pay for edges joining Ti to Tj for i 6= j. Thus, their total charge is at most 31−2α times their
total LP cost.
• Edges vz for which v ∈ {u} ∪ T and z ∈ S − ({u} ∪ T ) were charged at most max{ 11−2α , 2α} times
their LP cost.
• The bank was charged∑v∈V e(v). Thus, by Lemma 1, the total charge to the bank is at most 2C2.
It follows that the total cost is minimized when 31−2α =
2
α , which yields α = 2/7. For this choice of α, the
total charge is at most 7C1 + 2C2, which is at most 9 times the lower bound of 79C1 +
2
9C2.”
Given that the theoretical guarantees only establish approximation results, it is appropriate to compare the
solution of the proposed relaxation with the solution of the original ILP on synthetic data. For this purpose, we
created a simple graph comprising 35 vertices grouped into five clusters of size 6 and one cluster of size 5: in
order to ensure this cluster separation, we selected the weights as follows. For u, v ∈ V (G), we set
w+uv = γ, if u and v are in the same cluster (21)
w+uv = 1− γ, otherwise,
and w−uv = 1 − w+uv. We ran the ILP, the C3 algorithm, and the clu for γ ∈ {0.6, 0.7, 0.8, 0.9, 0.99}; all
three algorithms recovered the correct clusters without making errors. We subsequently modified the clusters
by randomly reversing the positive and negative weights of up to 20 edges. All three algorithms recovered the
correct clusters even in this scenario. Since large weight perturbations may change the clusters in a way that the
ground truth becomes undetectable, for larger scale perturbation we decided to compare the solution of the C3
algorithm to that of the ILP method. We again ran the ILP and C3 algorithms on a graph with 35 vertices, where
the positive weights, w+e , were chosen randomly according to a multinomial distribution; we also considered a
number of choices for the parameters of the distributions. The negative weights were chosen according to the
formula w−e = 1−w+e . For each set of weights, we compared the value of the objective function for the results
obtained using the two algorithms. We observed that in all cases the value of objective functions, denoted by f ,
satisfied
f(ILP) ≤ f(C3) < 2f(ILP), (22)
which shows that in practice, the C3 algorithm performed much better than suggested by the theoretical analysis.
Furthermore, the clusters generated by the ILP and the C3 algorithm showed more than 90% overlap in terms
of participating nodes.
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